Medically reviewed by Jeffrey S. Lander, MD Key Takeaways Combining blood pressure medications, such as a long-acting calcium channel blocker with an ACE inhibitor or ARB, is often more effective than ...

Angiotensin-converting-enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) have beneficial effects in patients with cardiovascular disease and in those with diabetes-related and ...

Discover comprehensive details about Angiotensin II, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated ...

Atrial fibrillation, or AFib, is the most common heart rhythm disorder. With AFib, the beating of the upper chambers of your heart (the atria) becomes irregular, and blood has a harder time reaching ...

Role of the RAAS in the Pathophysiology of Heart Failure ACE inhibitors have no effect on angiotensin II formed by alternate pathways. In contrast, ARBs would be expected to inhibit the biologic ...

Losartan may help stop the epileptic process in certain patients with hypertension. An observational study that analyzed medical records of 2.26 million patients with hypertension found a roughly 30% ...

In this study, we used the linked electronic health care records of 5.6 million persons in the United Kingdom from the Clinical Practice Research Datalink (CPRD) 4 to investigate the incidence of ...

Angiotensin II (AT-II)-Receptor Antagonists are Reviewed. Research focused on blocking the renin- angiotensin system (RAS) led to the discovery of angiotensin-converting-enzyme (ACE) inhibitors, which ...

Univariate Correlations between Changes in Aortic Diameter and TGF-β, MMP-2, and MMP-3 in Plasma. Collectively, these data 1,4 provide support for the concept that therapies targeting TGF-β and ...

Obesity and hypertension show up together in exam rooms every day.For many clinicians, the combination feels routine. A ...

STOCKHOLM, SE / ACCESS Newswire / April 29, 2026 /Vicore Pharma Holding AB (Nasdaq Stockholm:VICO), a clinical-stage biopharmaceutical company unlocking the potential of a novel class of drugs, ...